Iovance Biotherapeutics
IOVA
IOVA
173 hedge funds and large institutions have $2.25B invested in Iovance Biotherapeutics in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.68% more ownership
Funds ownership: 99.01% → 99.69% (+0.68%)
25% less capital invested
Capital invested by funds: $3B → $2.25B (-$749M)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
173
Holding in Top 10
8
Calls
$28.1M
Puts
$3.26M
Top Buyers
| 1 | +$37.1M | |
| 2 | +$24.3M | |
| 3 | +$21.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$11.9M |
Top Sellers
| 1 | -$76M | |
| 2 | -$39.2M | |
| 3 | -$30.9M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$16.4M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$9.33M |